Breast Cancer Update cover image

Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series

Breast Cancer Update

00:00

Oral Serds - Can You Do Better Than Full Vestrant?

Oral serds can overcome the issue that full vestrant necessarily cannot because of, you know, lack of oral bioavailability. Not every tumor can just get away with single agent endocrine therapy. We need combinations and such combinations are currently being evaluated in early stage either as an upfront strategy or as a swift strategy.

Play episode from 06:21
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app